PFM Health Sciences’s Baxter International BAX Stock Holding History

PFM Health Sciences’s Portfolio BAX Stock Details BAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-323,907	Closed	-$20.8M	–	87
2022 Q2	$20.8M	Buy	+323,907	New	+$23.5M	0.79%	47
2021 Q3	–	Sell	-458,667	Closed	-$36.9M	–	89
2021 Q2	$36.9M	Buy	458,667 +191	+0%	+$16K	1.16%	32
2021 Q1	$38.7M	Buy	+458,476	New	+$36.4M	1.18%	30
2020 Q3	–	Sell	-295,222	Closed	-$25.4M	–	77
2020 Q2	$25.4M	Sell	295,222 -14,413	-5%	-$1.26M	1.32%	32
2020 Q1	$25.1M	Buy	+309,635	New	+$26.7M	2.06%	21
2018 Q3	–	Sell	-865,121	Closed	-$63.9M	–	120
2018 Q2	$63.9M	Sell	865,121 -1,202,711	-58%	-$84.8M	1%	35
2018 Q1	$134M	Buy	2,067,832 +793,815	+62%	+$53.7M	2.73%	8
2017 Q4	$82.4M	Sell	1,274,017 -368,651	-22%	-$23.7M	1.95%	15
2017 Q3	$103M	Buy	1,642,668 +462,086	+39%	+$28.5M	2.03%	11
2017 Q2	$71.5M	Buy	1,180,582 +18,094	+2%	+$1.03M	1.93%	18
2017 Q1	$60.3M	Buy	+1,162,488	New	+$57.2M	1.51%	24
2016 Q4	–	Sell	-1,469,562	Closed	-$70M	–	97
2016 Q3	$70M	Buy	1,469,562 +113,019	+8%	+$5.33M	2.05%	13
2016 Q2	$61.3M	Buy	+1,356,543	New	+$59.5M	1.85%	19

Other funds holding BAX

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

PFM Health Sciences's BAX Position: Q3 2022 in Review

PFM Health Sciences sold out of Baxter International (BAX) in Q3 2022, closing a stake of 323,907 shares — an estimated $20.8M sold.

PFM Health Sciences first reported a position in BAX in Q2 2016 and held it in 13 quarters. The position peaked at $134M in Q1 2018. 1,011 funds tracked by Wall St. Rank hold BAX as of Q3 2022.

PFM Health Sciences reported no remaining Baxter International position as of Q3 2022 after selling out during the quarter.
PFM Health Sciences sold 323,907 Baxter International shares in Q3 2022, an estimated $20.8M.
PFM Health Sciences first reported a position in Baxter International in Q2 2016 and held it in 13 quarters.
PFM Health Sciences's Baxter International position peaked at $134M in Q1 2018.
1,011 funds tracked by Wall St. Rank held Baxter International as of Q3 2022.

Based on PFM Health Sciences's 13F filing for Q3 2022, filed 14 Nov 2022.